Dr. Dorsey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1825 4th St
San Francisco, CA 94143Phone+1 415-353-7337Fax+1 415-353-2568
Education & Training
- Boston Children’s HospitalFellowship, Allergy and Immunology, 2002 - 2005
- University of South Florida MorsaniResidency, Pediatrics, 1999 - 2002
- University of South Florida College of MedicineClass of 1999
Certifications & Licensure
- CA State Medical License 2013 - 2026
- FL State Medical License 2005 - 2023
- MA State Medical License 2005 - 2012
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Clinical Trials
- Registry Study of Revcovi Treatment in Patients With ADA-SCID Start of enrollment: 2019 Jun 25
Roles: Contact, Principal Investigator
- Allergic Disease Onset Prevention Study Start of enrollment: 2021 Sep 01
Roles: Contact
Publications & Presentations
PubMed
- Defining the Minimal Long-Term Follow-Up Data Elements for Newborn Screening.Yvonne Kellar-Guenther, Lauren Barringer, Katherine Raboin, Ginger Nichols, Kathy Y F Chou
International Journal of Neonatal Screening. 2024-05-15 - 2 citationsPosttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study.Hesham Eissa, Monica S Thakar, Ami J Shah, Brent R Logan, Linda M Griffith
The Journal of Allergy and Clinical Immunology. 2024-01-01 - 10 citationsGenotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.Jennifer W Leiding, Danielle E Arnold, Suhag Parikh, Brent Logan, Rebecca A Marsh
Blood. 2023-12-14
Press Mentions
- UCLA-Led Team Receives Funding to Study Valley FeverJune 14th, 2019
- FDA Approves RevcoviOctober 6th, 2018
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: